NCT06230614
Effect of Diluent Volume on Colistin Inhalation Therapy
StatusRecruiting
PhaseNot applicable
SponsorFu Jen Catholic University
Primary completion (estimated)
At risk: Primary completion moved 1 year 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Jul 31, 2026 to Dec 31, 2027
- Eligibility criteria expanded, about 6 words
- Notable Primary and study completion dates pushed to Jul 31, 2026v4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Feb 19, 2024 to Mar 10, 2024
- Site details revised
- Notable Eligibility criteria shortened, about 2 words
- Start date: Feb 1, 2024 to Feb 19, 2024
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Drug concentration
Timeframe: One hour post inhalation therapy with colistin on the third day of treatment
Arms and interventions
Colistin 1 MU in normal saline 1 mlActive comparator
1 MU of colistin in a total volume of 6 ml, diluted with a 1:1 ratio in normal saline (0.9%)
Colistin 1 MU in normal saline 2 mlExperimental
1 MU of colistin in a total volume of 12 ml, diluted with a 1:2 ratio in normal saline (0.9%)
Other: Colistin 1 MU in normal saline 1 ml, Colistin 1 MU in normal saline 2 ml
Sites
1 site in 1 country
- Fu Jen Catholic University Hospital, Fu Jen Catholic UniversityNew Taipei City, Taiwan